Stocks

─ CRc Response Rate 50% with Tuspetinib/Venetoclax Doublet in Evaluable Patients ─ ─ CRc 44% in Patients Who Failed Prior Venetoclax ─ ─ CRc 43% in Patients with Wildtype FLT3 ─ ─ CRc 67% in Patients with Mutated FLT3 ─ ─ Data Guide to …

Downer EDI (ASX:DOW) Full Year 2023 Results Key Financial Results Revenue: AU$11.7b (up 6.7% from FY 2022). Net loss: AU$385.7m (down by 365% from AU$145.7m profit in FY 2022). AU$0.59 loss per share (down from AU$0.21 profit in FY 2022). earnings-and-revenue-growth All figures shown …

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in trouble. When we see a declining return on capital employed (ROCE) in conjunction with a declining base of capital employed, that's often how …

Gross Profit of $11.9 million, up 4.9% yr/yr Adjusted EBITDA of $1.8 million in the quarter, up from ($4.1) million in Q2 2022 Company increases full-year Adjusted EBITDA guidance to $7.0 million to $9.0 million Subsequent to quarter end received ~87 million shares in …

VANCOUVER, British Columbia and BONHAM, Texas, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Kelso Technologies Inc. (“Kelso” or the “Company”), (TSX: KLS), (NYSE American: KIQ) reports that it has released its unaudited consolidated interim financial statements and Management Discussion and Analysis for the six months …

CALGARY, Alberta, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Sylogist Ltd. (TSX: SYZ) ("Sylogist" or the "Company"), a leading public sector SaaS company, today announced its Q2 financial results for the three months ending June 30, 2023. Q2 2023 Financial Highlights Record revenue of $16.7 …

NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES MISSISSAUGA, Ontario, March 05, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on …